0.4601
price up icon3.39%   0.0151
after-market Dopo l'orario di chiusura: .47 0.0099 +2.15%
loading

Alx Oncology Holdings Inc Azioni (ALXO) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
21.37%
37.76
48.02 53.27 36.78 32.20
Interest Income/Expense
2.89%
0.427
0.415 0.391 0.372 0.387
Depreciation and Amortization
0.00%
0.20
0.20 0.20 0.20 0.20
Operating Income/Loss
21.37%
-37.76
-48.02 -53.27 -36.78 -32.20
Income/Loss From Continuing Operations Before Tax
21.75%
-35.58
-45.47 -50.99 -34.16 -30.18
Income/Loss From Continuing Operations After Tax
21.75%
-35.58
-45.47 -50.99 -34.16 -30.18
Net Income/Loss
21.75%
-35.58
-45.47 -50.99 -34.16 -30.18
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,375%
50.12
2.0248 41.15 40.88 40.86
Diluted Average Shares
2,375%
50.12
2.0248 41.15 40.88 40.86
Basic Earnings Per Share
22.83%
-0.71
-0.92 -1.24 -0.84 -0.74
Diluted Earnings Per Share
22.83%
-0.71
-0.92 -1.24 -0.84 -0.74
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.30
price down icon 0.68%
$36.37
price up icon 0.50%
$24.55
price up icon 8.53%
$97.80
price down icon 0.45%
$110.00
price up icon 1.61%
biotechnology ONC
$245.49
price up icon 0.48%
Capitalizzazione:     |  Volume (24 ore):